Overview

A Phase 2A Trial of EPI-743 for Patients With Parkinson's Disease

Status:
Completed
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effects of EPI-743 in patients with Parkinson's disease.
Phase:
Phase 2
Details
Lead Sponsor:
University of South Florida
Collaborator:
Edison Pharmaceuticals Inc
Treatments:
Ubiquinone